70 /100
HIGH RISK
Score updated Apr 13, 2026

DRMA

Dermata Therapeutics, Inc. — Stock Dilution Tracker

Track DRMA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track DRMA — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
42
⚠️ Warrant Exposure
90
🔄Convertible Debt
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
54%
📜 Warrant Exercise 60%
• Massive warrant overhang: 135% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion 60%
• Major convertible overhang: 49% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 30%
• 50-day avg $1.42 approaching $1 threshold
🔔 Track DRMA — Get forecast alerts →
💹 Market Data
Market Cap$4.91M
Shares Outstanding4.02M
Float2.93M
Cash$7.52M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
7 institutional holders · 26.9K shares
#1 Clear Street Group Inc. 17.0K shares
#2 Bank of America Corporation 3.5K shares
#3 Barclays Plc 2.4K shares
+ 4 more holders Sign up free to view →
📉 Short Interest
Short Interest264.0K
Days to Cover1.0
% of Float9.0%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2022
Form 4 INSIDER TRANSACTION Feb 17, 2026
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track DRMA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DRMA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required